Pharma stocks experienced a significant surge after Finance Minister Nirmala Sitharaman announced the Rs 10,000 crore ...

Finance Minister Nirmala Sitharaman announces Biopharma Shakti, a ₹10,000 crore plan to boost biologics, biosimilars, clinical trials and regulatory capacity in India.

The Union Budget 2026–27 proposed a Rs 10,000 crore Bio Pharma Shakti scheme to boost biologics and biosimilars, alongside ...

Finance Minister Nirmala Sitharaman on Sunday proposed a Rs 10,000 crore allocation over the next five years to boost India’s ...

Nirmala Sitharaman presents Budget 2026 with a Yuva Shakti-driven roadmap, focusing on supporting the poor and inclusive ...

Finance Minister Nirmala Sitharaman on Sunday announced the Rs 10,000 crore ‘BioPharma Shakti’ initiative in Budget 2026 to ...

Union Budget 2026 unveiled a Rs 10,000 crore Biopharma Shakti mission to boost advanced medicine production, tackle rising diabetes and obesity, and strengthen India’s fight against non-communicable ...

The BioPharma Shakti initiative aims to strengthen research, clinical trials, and regulatory capacity amid India’s rising non ...

Finance Minister Nirmala Sitharaman has proposed setting up five medical tourism hubs and launching a ‘Biopharma Shakti ...

Union Finance Minister Nirmala Sitharaman announced a major new initiative in the Union Budget 2026, with the central government planning to launch the Bio Pharma Shakti scheme with an outlay of ...

Biopharma Shakti is a five-year program focused on boosting Indias capabilities in biologics, biosimilars and ...

Finance Minister Nirmala Sitharaman has proposed seven strategic and frontier sectors ranging from Rs 10,000-crore ‘Biopharma ...